[go: up one dir, main page]

SE366310B - Foerfarande foer framstaellning av scavelhaltige pyridinderivat - Google Patents

Foerfarande foer framstaellning av scavelhaltige pyridinderivat

Info

Publication number
SE366310B
SE366310B SE16705/69A SE1670569A SE366310B SE 366310 B SE366310 B SE 366310B SE 16705/69 A SE16705/69 A SE 16705/69A SE 1670569 A SE1670569 A SE 1670569A SE 366310 B SE366310 B SE 366310B
Authority
SE
Sweden
Prior art keywords
scavel
procedure
preparation
pyridine derivatives
containing pyridine
Prior art date
Application number
SE16705/69A
Other languages
English (en)
Swedish (sv)
Inventor
H Nowak
G Schorre
O Saiko
Original Assignee
Merck Ag E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Ag E filed Critical Merck Ag E
Publication of SE366310B publication Critical patent/SE366310B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE16705/69A 1968-12-05 1969-12-04 Foerfarande foer framstaellning av scavelhaltige pyridinderivat SE366310B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1812794A DE1812794C3 (de) 1968-12-05 1968-12-05 2-Methyl-3-hydroxy-5-methylthiomethylpyridinderivate und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
SE366310B true SE366310B (sv) 1974-04-22

Family

ID=5715283

Family Applications (1)

Application Number Title Priority Date Filing Date
SE16705/69A SE366310B (sv) 1968-12-05 1969-12-04 Foerfarande foer framstaellning av scavelhaltige pyridinderivat

Country Status (16)

Country Link
US (2) US3658825A (de)
JP (1) JPS5243834B1 (de)
AT (4) AT309430B (de)
BE (1) BE742641A (de)
BR (1) BR6914813D0 (de)
CH (4) CH545291A (de)
CS (3) CS164837B2 (de)
DE (1) DE1812794C3 (de)
DK (1) DK141050B (de)
ES (1) ES374266A1 (de)
FR (1) FR2025454A1 (de)
GB (1) GB1263370A (de)
IL (1) IL33437A (de)
IT (1) IT7947631A0 (de)
NL (1) NL167421C (de)
SE (1) SE366310B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336441A (en) * 1991-05-29 1994-08-09 Petrolite Corporation Corrosion inhibition in highly acidic environments by use of pyridine salts in combination with certain cationic surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1220422B (de) * 1963-09-07 1966-07-07 Merck Ag E Verfahren zur Herstellung eines neuen Bis-pyridyl-methyl-disulfids
US3525749A (en) * 1969-03-19 1970-08-25 Merck & Co Inc Certain 1,3-dioxepino-(5,6-c)-pyridines

Also Published As

Publication number Publication date
CH562797A5 (de) 1975-06-13
CS164837B2 (de) 1975-11-28
FR2025454B1 (de) 1974-05-24
ES374266A1 (es) 1972-03-16
AT311970B (de) 1973-12-10
CH544756A (de) 1973-11-30
GB1263370A (en) 1972-02-09
US3759930A (en) 1973-09-18
DK141050C (de) 1980-06-16
US3658825A (en) 1972-04-25
DE1812794C3 (de) 1978-10-05
BR6914813D0 (pt) 1973-03-08
AT309427B (de) 1973-08-27
DE1812794A1 (de) 1970-07-02
IL33437A0 (en) 1970-01-29
AT309430B (de) 1973-08-27
IL33437A (en) 1973-03-30
CH545291A (de) 1974-01-31
NL6918252A (nl) 1970-06-09
JPS5243834B1 (de) 1977-11-02
CH544757A (de) 1974-01-15
DE1812794B2 (de) 1978-02-02
NL167421C (nl) 1981-12-16
AT311347B (de) 1973-11-12
BE742641A (fr) 1970-06-04
CS164836B2 (de) 1975-11-28
CS164838B2 (de) 1975-11-28
DK141050B (da) 1979-12-31
FR2025454A1 (fr) 1970-09-11
NL167421B (nl) 1981-07-16
IT7947631A0 (it) 1979-01-15

Similar Documents

Publication Publication Date Title
SE402284B (sv) Forfarande for framstellning av pyridinderivat
SE382459B (sv) Forfarande for framstellning av xantonderivat.
SE383887B (sv) Analogiforfarande for framstellning av alfa-amino-cyklohexadienyl-alkylen-penicilliner
SE382065B (sv) Forfarande for framstellning av linkomycinderivat
SE386439B (sv) Forfarande for framstellning av aminosubstituerade pyridinderivat
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
ES376781A0 (es) Procedimiento para la preparacion de derivados de piridina sustituidos
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE397971B (sv) Forfarande for framstellning av halogenmetyl-1,3-polyhalogen-2-propyletrar
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
IL43886A0 (en) The preparation of quinoline derivatives
SE380796B (sv) Forfarande for framstellning av cyklopentanderivat
SE380528B (sv) Forfarande for framstellning av 2-klor-7-hydroxi-11-piperazinyldibensoxazepmderivat
SE398232B (sv) Forfarande for framstellning av bensodiazepinderivat
NO136538C (no) Fremgangsm}te for fremstilling av indolderivater
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
NO136409C (no) Fremgangsm}te for fremstilling av aryloksyalkyl-morfolinderivater
NO137050C (no) Fremgangsm}te til fremstilling av butyrofenonderivater
SE385898B (sv) Forfarande for framstellning av cefalosporiner